×
We recently upgraded the website!  If you run into any issues, please Contact Us.  We'd also love to hear your feedback!  Enjoy exploring the new site!
  1. You are here:
  2. Homepage
  3. News & Insights Search
  4. Are you ready to begin planning your IND?

 

Sponsored Content
March 3, 2021
by Kevin Hennegan

Are you ready to begin planning your IND?

Submitting an Investigational New Drug (IND) application to the US Food and Drug Adminstration is a significant step in the development of a new drug or biologic product. But how do you know when it is time to begin the process of preparing and submitting your IND? 

In a webinar replay, Veristat experts explore the minimum required content for an IND submission and the strategic considerations for developing more than the minimum necessary data before filing an IND.

View the webinar replay to help you better understand:
  • Drug development overview
  • Purpose of an IND
  • When do you have enough data?
  • Value of a pre-IND meeting
Kevin Hennegan is a senior regulatory strategist at Veristat. 
Return to listing
×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.